SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
WILMINGTON, Del., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of ERBA Diagnostics, Inc. (NYSE MKT:ERB)?
- Did you purchase your shares between April 14, 2014 and November 20, 2015, inclusive?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. reminds shareholders of ERBA Diagnostics, Inc. (“ERBA” or the “Company”) (NYSE MKT:ERB) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. A complaint was filed in the United States District Court for the Southern District of Florida on behalf of all persons or entities that purchased the common stock of ERBA between April 14, 2014 and November 20, 2015, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you wish to serve as lead plaintiff, you must move the Court no later than February 1, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you purchased shares of ERBA during the Class Period, or purchased shares prior to the Class Period and still hold ERBA, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/erba-diagnostics-inc-erb.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com
